These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32978031)

  • 1. Congenital myasthenic syndromes in the Thai population: Clinical findings and novel mutations.
    Pattrakornkul N; Ittiwut C; Boonsimma P; Boonyapisit K; Khongkhatithum C; Sanmaneechai O; Suphapeetiporn K; Shotelersuk V
    Neuromuscul Disord; 2020 Oct; 30(10):851-858. PubMed ID: 32978031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.
    Laforgia N; De Cosmo L; Palumbo O; Ranieri C; Sesta M; Capodiferro D; Pantaleo A; Iapicca P; Lastella P; Capozza M; Schettini F; Bukvic N; Bagnulo R; Resta N
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33353066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect.
    Guo Y; Menezes MJ; Menezes MP; Liang J; Li D; Riley LG; Clarke NF; Andrews PI; Tian L; Webster R; Wang F; Liu X; Shen Y; Thorburn DR; Keating BJ; Engel A; Hakonarson H; Christodoulou J; Xu X
    Neuromuscul Disord; 2015 Mar; 25(3):257-61. PubMed ID: 25557462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
    Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
    Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
    Saito M; Ogasawara M; Inaba Y; Osawa Y; Nishioka M; Yamauchi S; Atsumi K; Takeuchi S; Imai K; Motobayashi M; Misawa Y; Iida A; Nishino I
    Brain Dev; 2022 Jan; 44(1):50-55. PubMed ID: 34565654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
    Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
    Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First characterization of congenital myasthenic syndrome type 5 in North Africa.
    Khaoula R; Cerino M; Da Silva N; Delague V; Nahili H; Kriouile Y; Gorokhova S; Bartoli M; Saïle R; Barakat A; Krahn M
    Mol Biol Rep; 2021 Oct; 48(10):6999-7006. PubMed ID: 34553317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Landscape of Congenital Myasthenic Syndromes From Turkey: Novel Mutations and Clinical Insights.
    Yiş U; Becker K; Kurul SH; Uyanik G; Bayram E; Haliloğlu G; Polat Aİ; Ayanoğlu M; Okur D; Tosun AF; Serdaroğlu G; Yilmaz S; Topaloğlu H; Anlar B; Cirak S; Engel AG
    J Child Neurol; 2017 Jul; 32(8):759-765. PubMed ID: 28464723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel copy number variation of COLQ gene in a Moroccan patient with congenital myasthenic syndrome: a case report and review of the literature.
    El Kadiri Y; Ratbi I; Sefiani A; Lyahyai J
    BMC Neurol; 2022 Aug; 22(1):292. PubMed ID: 35932018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COLQ-related congenital myasthenic syndrome: An integrative view.
    Eshaghian T; Rabbani B; Badv RS; Mikaeeli S; Gharib B; Iyadurai S; Mahdieh N
    Neurogenetics; 2023 Jul; 24(3):189-200. PubMed ID: 37231228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
    Selvam P; Arunachal G; Danda S; Chapla A; Sivadasan A; Alexander M; Thomas MM; Thomas NJ
    J Clin Neuromuscul Dis; 2018 Sep; 20(1):14-27. PubMed ID: 30124556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature.
    Mishra S; Nair KV; Shukla A
    Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.
    Tay CG; Fong CY; Li L; Ganesan V; Teh CM; Gan CS; Thong MK
    J Clin Neurosci; 2020 Feb; 72():468-471. PubMed ID: 31831253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital myasthenic syndrome: a brief review.
    Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
    Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
    Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
    Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
    Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
    Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
    Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
    Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.